Stock AMPE AMPIO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Ampio Pharmaceuticals, Inc.

Equities

AMPE

US03209T3077

Delayed OTC Markets
Other stock markets
 14:30:00 09/05/2024 BST 		5-day change 1st Jan Change
0.22 USD -20.23% Intraday chart for Ampio Pharmaceuticals, Inc. -12.70% -89.27%
04-15 Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index CI
03-27 Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ampio Pharmaceuticals Extends Chief Executive Michael Martino's Employment; Shares Up
MT
Ampio Pharmaceuticals Fires Two Executives After Investigation
DJ
Ampio Pharmaceuticals, Inc. Announces Executive Changes
CI
Ampio Pharmaceuticals Appoints Elizabeth Varki Jobes as Member of the Board and as Member of the Nominating and Corporate Governance Committee of the Board
CI
Ampio Pharmaceuticals Chief Executive Mike Macaluso Takes Medical Leave; Interim Replacement Named
MT
Ampio Pharmaceuticals, Inc. Announces Executive Changes
CI
Ampio Pharmaceuticals, Inc. Announces Executive Changes
CI
Ampio Pharmaceuticals Strengthens Management Team and Board of Directors
CI
Ampio Pharmaceuticals, Inc. Appoints Willam Bindley and Bruce E. Terker to Newly Formed Transaction Advisory Committee
CI
Ampio Pharmaceuticals, Inc. Appoints Dan Stokely as Chief Financial Officer and Corporate Secretary
CI
Thomas E. Chilcott, III Resigns as Chief Financial Officer, Treasurer and Secretary of Ampio Pharmaceuticals, Inc
CI
David Bar-Or Retires as Chief Scientific Officer of Ampio Pharmaceuticals, Inc., Effective September 30, 2018
CI
Ampio Pharmaceuticals, Inc. Appoints Holli Cherevka as Chief Operating Officer, Effective September 19, 2017
CI
Ampio Pharmaceuticals, Inc. Appoints Thomas E. Chilcott, III as Chief Financial Officer
CI
Ampio Pharmaceuticals, Inc. Announces Resignation of Joshua R. Disbrow as Chief Operating Officer
CI
Ampio Pharmaceuticals, Inc. Announces Executive Changes
CI
Ampio Pharmaceuticals, Inc. Appoints Josh Disbrow as Chief Operating Officer, Effective December 15, 2012
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AMPE Stock
  4. News Ampio Pharmaceuticals, Inc.
  5. Insiders